284 related articles for article (PubMed ID: 19416968)
21. The combination of ezetimibe and ursodiol promotes fecal sterol excretion and reveals a G5G8-independent pathway for cholesterol elimination.
Wang Y; Liu X; Pijut SS; Li J; Horn J; Bradford EM; Leggas M; Barrett TA; Graf GA
J Lipid Res; 2015 Apr; 56(4):810-20. PubMed ID: 25635125
[TBL] [Abstract][Full Text] [Related]
22. Liver-specific induction of Abcg5 and Abcg8 stimulates reverse cholesterol transport in response to ezetimibe treatment.
Altemus JB; Patel SB; Sehayek E
Metabolism; 2014 Oct; 63(10):1334-41. PubMed ID: 25060694
[TBL] [Abstract][Full Text] [Related]
23. Hepatic SR-BI, not endothelial lipase, expression determines biliary cholesterol secretion in mice.
Wiersma H; Gatti A; Nijstad N; Kuipers F; Tietge UJ
J Lipid Res; 2009 Aug; 50(8):1571-80. PubMed ID: 19252221
[TBL] [Abstract][Full Text] [Related]
24. Studies on LXR- and FXR-mediated effects on cholesterol homeostasis in normal and cholic acid-depleted mice.
Wang J; Einarsson C; Murphy C; Parini P; Björkhem I; Gåfvels M; Eggertsen G
J Lipid Res; 2006 Feb; 47(2):421-30. PubMed ID: 16264196
[TBL] [Abstract][Full Text] [Related]
25. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters.
Berge KE; Tian H; Graf GA; Yu L; Grishin NV; Schultz J; Kwiterovich P; Shan B; Barnes R; Hobbs HH
Science; 2000 Dec; 290(5497):1771-5. PubMed ID: 11099417
[TBL] [Abstract][Full Text] [Related]
26. Scavenger receptor class B type I mediates biliary cholesterol secretion independent of ATP-binding cassette transporter g5/g8 in mice.
Wiersma H; Gatti A; Nijstad N; Oude Elferink RP; Kuipers F; Tietge UJ
Hepatology; 2009 Oct; 50(4):1263-72. PubMed ID: 19637290
[TBL] [Abstract][Full Text] [Related]
27. NPC1L1 and ABCG5/8 induction explain synergistic fecal cholesterol excretion in ob/ob mice co-treated with PPAR-α and LXR agonists.
Srivastava RAK; Cefalu AB; Srivastava NS; Averna M
Mol Cell Biochem; 2020 Oct; 473(1-2):247-262. PubMed ID: 32661772
[TBL] [Abstract][Full Text] [Related]
28. Pharmacological activation of liver X receptors promotes reverse cholesterol transport in vivo.
Naik SU; Wang X; Da Silva JS; Jaye M; Macphee CH; Reilly MP; Billheimer JT; Rothblat GH; Rader DJ
Circulation; 2006 Jan; 113(1):90-7. PubMed ID: 16365197
[TBL] [Abstract][Full Text] [Related]
29. Activation of liver X receptor decreases atherosclerosis in Ldlr⁻/⁻ mice in the absence of ATP-binding cassette transporters A1 and G1 in myeloid cells.
Kappus MS; Murphy AJ; Abramowicz S; Ntonga V; Welch CL; Tall AR; Westerterp M
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):279-84. PubMed ID: 24311381
[TBL] [Abstract][Full Text] [Related]
30. Ezetimibe stimulates faecal neutral sterol excretion depending on abcg8 function in mice.
Jakulj L; Vissers MN; van Roomen CP; van der Veen JN; Vrins CL; Kunne C; Stellaard F; Kastelein JJ; Groen AK
FEBS Lett; 2010 Aug; 584(16):3625-8. PubMed ID: 20659465
[TBL] [Abstract][Full Text] [Related]
31. The effect of T0901317 on ATP-binding cassette transporter A1 and Niemann-Pick type C1 in apoE-/- mice.
Dai XY; Ou X; Hao XR; Cao DL; Tang YL; Hu YW; Li XX; Tang CK
J Cardiovasc Pharmacol; 2008 May; 51(5):467-75. PubMed ID: 18437096
[TBL] [Abstract][Full Text] [Related]
32. Pravastatin Modulate Niemann-Pick C1-Like 1 and ATP-Binding Cassette G5 and G8 to Influence Intestinal Cholesterol Absorption.
Kawase A; Hata S; Takagi M; Iwaki M
J Pharm Pharm Sci; 2015; 18(5):765-72. PubMed ID: 26670369
[TBL] [Abstract][Full Text] [Related]
33. Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors alpha and beta.
Repa JJ; Berge KE; Pomajzl C; Richardson JA; Hobbs H; Mangelsdorf DJ
J Biol Chem; 2002 May; 277(21):18793-800. PubMed ID: 11901146
[TBL] [Abstract][Full Text] [Related]
34. LXR agonist suppresses atherosclerotic lesion growth and promotes lesion regression in apoE*3Leiden mice: time course and mechanisms.
Verschuren L; de Vries-van der Weij J; Zadelaar S; Kleemann R; Kooistra T
J Lipid Res; 2009 Feb; 50(2):301-11. PubMed ID: 18757914
[TBL] [Abstract][Full Text] [Related]
35. Selective sterol accumulation in ABCG5/ABCG8-deficient mice.
Yu L; von Bergmann K; Lutjohann D; Hobbs HH; Cohen JC
J Lipid Res; 2004 Feb; 45(2):301-7. PubMed ID: 14657202
[TBL] [Abstract][Full Text] [Related]
36. Effect of a liver X receptor agonist on deposition and lymphatic absorption of plant sterols in stroke-prone spontaneously hypertensive rats having a mutation in ATP-binding cassette transporter G5.
Hamada T; Kudo M; Sato M; Inoue N; Nagao K; Imaizumi K; Ikeda I
Biosci Biotechnol Biochem; 2011; 75(12):2359-63. PubMed ID: 22146733
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol.
Yu L; Li-Hawkins J; Hammer RE; Berge KE; Horton JD; Cohen JC; Hobbs HH
J Clin Invest; 2002 Sep; 110(5):671-80. PubMed ID: 12208868
[TBL] [Abstract][Full Text] [Related]
38. EP 80317, a CD36 selective ligand, promotes reverse cholesterol transport in apolipoprotein E-deficient mice.
Bujold K; Mellal K; Zoccal KF; Rhainds D; Brissette L; Febbraio M; Marleau S; Ong H
Atherosclerosis; 2013 Aug; 229(2):408-14. PubMed ID: 23880196
[TBL] [Abstract][Full Text] [Related]
39. Evidence that the adenosine triphosphate-binding cassette G5/G8-independent pathway plays a determinant role in cholesterol gallstone formation in mice.
Wang HH; Li X; Patel SB; Wang DQ
Hepatology; 2016 Sep; 64(3):853-64. PubMed ID: 27014967
[TBL] [Abstract][Full Text] [Related]
40. Hepatic ABCG5/G8 overexpression substantially increases biliary cholesterol secretion but does not impact in vivo macrophage-to-feces RCT.
Dikkers A; de Boer JF; Groen AK; Tietge UJ
Atherosclerosis; 2015 Dec; 243(2):402-6. PubMed ID: 26520893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
